James J. Armstrong BSc

Uczestniczy w 4 elementy

Elementy, w których James J. Armstrong BSc uczestniczy

niedziela 3 czerwiec, 2018

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
16:40
Acetylsalicylic acid reduces collagen contraction, remodelling and myofibroblast proliferation in Tenon's Capsule tissue mimetic
16:41 - 16:47 | 6 min.
Second Prize, COS Awards of ExcellenceAward Winner

piątek 14 czerwiec, 2019

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
14:15
Acetylation of COX-2: An immunoresolving therapy
14:19 - 14:27 | 8 min.
UveitisSecond Prize, COS Awards of Excellence

sobota 27 czerwiec, 2020

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
14:30
Development of an injectable, space-filling thermosensitive hydrogel as a subconjunctival bleb scaffold and sustained release drug depot
Vancouver Convention Centre (East Building) - Exhibit Hall A
14:34 - 14:41 | 7 min.
Glaucoma

piątek 10 czerwiec, 2022

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
15:50
Effect of Subconjunctival Microshunt Implantation on Intraocular Pressure Variation in Patients with Glaucoma
Halifax Convention Centre - C1
15:51 - 15:59 | 8 min.
Glaucoma

Authors: James J. Armstrong, Matthew B. Schlenker, Iqbal Ike Ahmed. University of Toronto.Author Disclosure Block: J.J. Armstrong: None. M.B. Schlenker: Santen Pharmaceutical Co.; Alcon ; Allergan; Johnson & Johnson Vision; Labtician Thea; Light Matter Interaction Inc.  I.I. Ahmed: